Table 3.
Advantages | Disadvantages | |
---|---|---|
Antibodies | Specific affinity with POIs 74 | High cost; low stability and tissue permeability 21; potential immunogenicity 52 |
Small molecules | High stability 75; good penetrability 25 |
Inability to target “undruggable proteins” 25 |
Peptides | Low cost; easy to synthesise 61 |
Low stability; limited penetrability 36 |